UK
UK
Jun-15
Endocrinology Pharmacoepidemiology
Read moreJun-15
Apr-15
Endocrinology Pharmacoepidemiology
Read moreApr-15
Endocrinology Gastroenterology Oncology Pharmacoepidemiology
Read moreApr-15
Cardiovascular Endocrinology Nephrology
Read moreApr-15
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreFeb-15
Cardiovascular Database Endocrinology
Read moreFeb-15
Endocrinology Pharmacoepidemiology
Read moreFeb-15
Cardiovascular Endocrinology Ophthalmology
Read moreDec-14
Nov-14
Sep-14
Endocrinology Healthcare Cost Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Jun-15 | Comparative Efficacy of Adding Sitagliptin to Metformin, Sulfonylurea or Dual Therapy: A Propensity Score-Weighted Cohort Study | Read more | |
| Jun-15 | The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study | Read more | |
| Apr-15 | Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs | Read more | |
| Apr-15 | Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk |
Endocrinology Gastroenterology Oncology Pharmacoepidemiology |
Read more |
| Apr-15 | Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors | Read more | |
| Apr-15 | A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK | Read more | |
| Feb-15 | Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK | Read more | |
| Feb-15 | Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes | Read more | |
| Feb-15 | Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population | Read more | |
| Dec-14 | Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK | Read more | |
| Nov-14 | Comparing the Use of Patient-Level Data to An Average Patient Profile Within a Type 2 Diabetes Simulation Model | Read more | |
| Sep-14 | The cost-effectiveness of canagliflozin (CANA) versus sitagliptin (SITA) as third-line therapy in the treatment of type 2 diabetes mellitus (T2DM) in the UK | Read more |
